Ardelyx Share Price (NASDAQ: ARDX)

$6.36

▲

0.17

(2.75%)

Live

Last updated on August 28, 2025 at 11:42 pm IST

$₹

Check the interactive Ardelyx Stock chart to analyse performance

Ardelyx stock performance

as on August 28, 2025 at 11:42 pm IST

Today's Low:$6.19
Today's High:$6.36
$6.36
2.67%
Downside
Day's Volatility :2.67%
Upside
0.0%
52 Weeks Low:$3.21
52 Weeks High:$7.18
$6.36
49.53%
Downside
52 Weeks Volatility :55.29%
Upside
11.42%

Ardelyx Stock Returns

Period	Ardelyx Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	53.6%	4.2%	0.0%
6 Months	18.58%	-8.0%	0.0%
1 Year	0.65%	-12.1%	0.0%
3 Years	521.74%	7.6%	-6.9%

Ardelyx Inc Key Stats

Check Ardelyx key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$6.19
Open	$6.185
Today's High	$6.42
Today's Low	$6.19
Market Capitalization	$1.5B
Today's Volume	$2.5M
52 Week High	$7.18
52 Week Low	$3.21
Revenue TTM	$386.1M
EBITDA	$-38.1M
Earnings Per Share (EPS)	$-0.24
Profit Margin	-14.6%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-39.36%

Stock Returns calculator for Ardelyx Stock including INR - Dollar returns

The Ardelyx stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Ardelyx investment value today

Current value as on today

₹1,07,774

Returns

₹7,774

(+7.77%)

Returns from Ardelyx Stock

₹3,415 (+3.41%)

Dollar Returns*

₹4,360 (+4.36%)

Indian investors sentiment towards Ardelyx Stock

-11%

Period: Jul 28, 2025 to Aug 27, 2025. Change in 30 Days versus previous period

Search interest for Ardelyx Stock from India on INDmoney has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Ardelyx Inc

Name
Holdings %
Name
Holdings %
BlackRock Inc
7.45%
Vanguard Group Inc
6.65%
HHG PLC
6.25%
Marshall Wace Asset Management Ltd
4.67%
Macquarie Group Ltd
4.63%
State Street Corp
4.22%

Analyst Recommendation on Ardelyx Stock

Rating

Trend

Buy

93%Buy

6%Hold

0%Sell

Based on 16 Wall street analysts offering stock ratings for Ardelyx(by analysts ranked 0 to 5 stars)

Ardelyx Share Price Target

What analysts predicted

Upside of 75.81%

Target:

$11.18

Current:

$6.36

Ardelyx share price target is $11.18, a slight Upside of 75.81% compared to current price of $6.36 as per analysts' prediction.

Ardelyx Stock Insights

Price Movement
In the last 1 month, ARDX stock has moved up by 44.6%
Increasing Revenue
Revenue is up for the last 2 quarters, 74.11M → 97.66M (in $), with an average increase of 24.1% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -41.14M → -19.07M (in $), with an average increase of 115.7% per quarter
ARDX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.8% return, outperforming this stock by 61.1%
Price to Sales
ForARDX every $1 of sales, investors are willing to pay $3.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.9 for every $1 of sales.

Ardelyx Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$5.3M	↑ 102.57%
Net Income	$-94.9M	↑ 3.99%
Net Profit Margin	-1.8K%	↑ 1704.26%

	FY20	Y/Y Change
Revenue	$7.6M	↑ 43.36%
Net Income	$-94.3M	↓ 0.66%
Net Profit Margin	-1.2K%	↑ 552.06%

	FY21	Y/Y Change
Revenue	$10.1M	↑ 33.36%
Net Income	$-158.2M	↑ 67.7%
Net Profit Margin	-1.6K%	↓ 320.75%

	FY22	Y/Y Change
Revenue	$52.2M	↑ 416.57%
Net Income	$-67.2M	↓ 57.51%
Net Profit Margin	-128.85%	↑ 1437.61%

	FY23	Y/Y Change
Revenue	$124.5M	↑ 138.61%
Net Income	$-66.1M	↓ 1.7%
Net Profit Margin	-53.08%	↑ 75.77%

	FY24	Y/Y Change
Revenue	$333.6M	↑ 168.06%
Net Income	$-39.1M	↓ 40.76%
Net Profit Margin	-11.73%	↑ 41.35%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$46.0M	↑ 33.93%
Net Income	$-26.5M	↓ 7.93%
Net Profit Margin	-57.62%	↑ 26.2%

	Q2 FY24	Q/Q Change
Revenue	$73.2M	↑ 59.1%
Net Income	$-16.5M	↓ 37.95%
Net Profit Margin	-22.47%	↑ 35.15%

	Q3 FY24	Q/Q Change
Revenue	$98.2M	↑ 34.17%
Net Income	$-809.0K	↓ 95.08%
Net Profit Margin	-0.82%	↑ 21.65%

	Q4 FY24	Q/Q Change
Revenue	$116.1M	↑ 18.21%
Net Income	$4.6M	↓ 674.17%
Net Profit Margin	4.0%	↑ 4.82%

	Q1 FY25	Q/Q Change
Revenue	$74.1M	↓ 36.18%
Net Income	$-41.1M	↓ 985.77%
Net Profit Margin	-55.51%	↓ 59.51%

	Q2 FY25	Q/Q Change
Revenue	$97.7M	↑ 31.77%
Net Income	$-19.1M	↓ 53.63%
Net Profit Margin	-19.54%	↑ 35.97%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$4.7M	↑ 118.64%

	FY20	Y/Y Change
Profit	$7.4M	↑ 58.64%

	FY21	Y/Y Change
Profit	$9.1M	↑ 22.5%

	FY22	Y/Y Change
Profit	$48.0M	↑ 428.1%

	FY23	Y/Y Change
Profit	$106.7M	↑ 122.02%

	FY24	Y/Y Change
Profit	$283.1M	↑ 165.38%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$38.5M	↑ 31.33%

	Q2 FY24	Q/Q Change
Profit	$63.2M	↑ 64.37%

	Q3 FY24	Q/Q Change
Profit	$82.5M	↑ 30.52%

	Q4 FY24	Q/Q Change
Profit	$97.9M	↑ 18.61%

	Q1 FY25	Q/Q Change
Profit	$64.2M	↓ 34.45%

	Q2 FY25	Q/Q Change
Profit	$85.3M	↑ 32.9%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-76.5M	↑ 8.84%
Investing Cash Flow	$23.4M	↓ 178.19%
Financing Cash Flow	$155.5M	↑ 50.14%

	FY20	Y/Y Change
Operating Cash Flow	$-81.4M	↑ 6.47%
Investing Cash Flow	$-31.4M	↓ 234.52%
Financing Cash Flow	$22.8M	↓ 85.35%

	FY21	Y/Y Change
Operating Cash Flow	$-152.6M	↑ 87.33%
Investing Cash Flow	$50.9M	↓ 262.04%
Financing Cash Flow	$83.0M	↑ 264.41%

	FY22	Y/Y Change
Operating Cash Flow	$-70.0M	↓ 54.08%
Investing Cash Flow	$18.4M	↓ 63.86%
Financing Cash Flow	$75.3M	↓ 9.23%

	FY23	Y/Y Change
Operating Cash Flow	$-89.7M	↑ 28.09%
Investing Cash Flow	$-131.2M	↓ 812.72%
Financing Cash Flow	$146.3M	↑ 94.18%

	FY24	Y/Y Change
Operating Cash Flow	$-44.8M	↓ 50.06%
Investing Cash Flow	$-18.3M	↓ 86.04%
Financing Cash Flow	$106.6M	↓ 27.14%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-35.7M	↑ 309.75%
Investing Cash Flow	$-2.6M	↓ 91.3%
Financing Cash Flow	$53.0M	↑ 103.83%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-19.4M	↓ 45.7%
Investing Cash Flow	$23.5M	↓ 1014.97%
Financing Cash Flow	$1.6M	↓ 96.96%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$501.0K	↓ 102.58%
Investing Cash Flow	$2.3M	↓ 90.05%
Financing Cash Flow	$2.7M	↑ 67.72%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$9.8M	↑ 1858.08%
Investing Cash Flow	$-41.6M	↓ 1877.87%
Financing Cash Flow	$49.3M	↑ 1728.44%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-38.5M	↓ 492.02%
Investing Cash Flow	$2.9M	↓ 106.85%
Financing Cash Flow	$1.5M	↓ 96.99%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-25.3M	↓ 34.1%
Investing Cash Flow	$34.9M	↑ 1124.94%
Financing Cash Flow	$49.7M	↑ 3250.61%

Ardelyx Technicals Summary

Sell

Neutral

Buy

Ardelyx is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Ardelyx Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Ardelyx Inc	46.68%	18.58%	0.65%	521.74%	7.84%
Regeneron Pharmaceuticals, Inc.	5.16%	-16.48%	-51.06%	-0.98%	-5.32%
Beone Medicines Ltd	-1.83%	7.82%	51.46%	79.4%	24.25%
Vertex Pharmaceuticals Incorporated	-16.94%	-18.0%	-20.55%	38.17%	39.4%
Alnylam Pharmaceuticals, Inc.	37.4%	91.56%	61.8%	117.28%	242.42%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Ardelyx Inc	NA	NA	-0.08	-0.36	-0.39	-0.06	NA	0.58
Regeneron Pharmaceuticals, Inc.	14.86	14.86	1.21	39.42	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.73	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.58	27.58	0.58	18.06	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Ardelyx Inc	Buy	$1.5B	7.84%	NA	-14.6%
Regeneron Pharmaceuticals, Inc.	Buy	$62.5B	-5.32%	14.86	31.37%
Beone Medicines Ltd	NA	$37.7B	24.25%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$99.3B	39.4%	27.58	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$59.1B	242.42%	NA	-12.96%

About Ardelyx Inc

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Organization	Ardelyx
Employees	395
CEO	Mr. Michael G. Raab
Industry	Health Technology

Key Management of Ardelyx Inc

Name	Title
Mr. Michael G. Raab	President, CEO & Director
Mr. Justin A. Renz CPA, MBA	Chief Financial & Operations Officer
Ms. Elizabeth A. Grammer Esq.	Chief Legal & Administrative Officer and Secretary
Dr. Laura A. Williams M.D., M.P.H.	Chief Patient Officer
Mr. Mike Kelliher	Chief Business Officer
Mr. Joseph Reilly	Senior VP of Finance & Principal Accounting Officer
Ms. Caitlin Lowie	Vice President of Corporate Communications & Investor Relations
Mr. James P. Brady	Chief Human Resources Officer

Important FAQs about investing in ARDX Stock from India :

What is Ardelyx share price today?

Ardelyx share price today is $6.36 as on August 28, 2025 at 11:42 pm IST. Ardelyx share today touched a day high of $6.36 and a low of $6.19.

What is the 52 week high and 52 week low for Ardelyx share?

Ardelyx share touched a 52 week high of $7.18 and a 52 week low of $3.21. Ardelyx stock price today i.e. August 28, 2025 at 11:42 pm IST is trending at $6.36, lower by 11.42% versus the 52 week high.

How to invest in Ardelyx Stock (ARDX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Ardelyx on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ardelyx Shares that will get you 0.2358 shares as per Ardelyx share price of $6.36 per share as on August 28, 2025 at 11:42 pm IST.

What is the minimum amount required to buy Ardelyx Stock (ARDX) from India?

Indian investors can start investing in Ardelyx (ARDX) shares with as little as ₹87.587 or $1 (as of August 28, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.87 in Ardelyx stock (as per the Rupee-Dollar exchange rate as on August 28, 2025). Based on Ardelyx share’s latest price of $6.36 as on August 28, 2025 at 11:42 pm IST, you will get 1.5723 shares of Ardelyx. Learn more about fractional shares .

What are the returns that Ardelyx has given to Indian investors in the last 5 years?

Ardelyx stock has given 7.84% share price returns and 18.52% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?